bremazocine has been researched along with nalorphine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (62.50) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burks, TF; Hirning, LD; Porreca, F | 1 |
Hayes, A; Kelly, A | 1 |
Hart, JC; Leander, JD; Zerbe, RL | 1 |
Iwamoto, ET; Martin, WR | 1 |
Code, RA; Tang, AH | 1 |
Holtzman, SG; Powell, KR | 1 |
Barrett, AC; Cook, CD; Picker, MJ; Roach, EL; Syvanthong, C; Terner, JM | 1 |
Chen, G; Goddard, WA; Kim, SK; Li, Q; Tan, H | 1 |
1 review(s) available for bremazocine and nalorphine
Article | Year |
---|---|
Multiple opioid receptors.
Topics: Analgesics; Animals; Behavior, Animal; Benzomorphans; Cyclazocine; Discrimination Learning; Dogs; Dopamine; Drug Tolerance; Electroencephalography; Humans; Macaca mulatta; Mice; Morphine; Morphine Dependence; Motor Activity; Nalorphine; Pain; Rabbits; Rats; Receptors, Dopamine; Receptors, Opioid; Receptors, Opioid, kappa; Seizures; Temperature | 1981 |
7 other study(ies) available for bremazocine and nalorphine
Article | Year |
---|---|
Mu, but not kappa, opioid agonists induce contractions of the canine small intestine ex vivo.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Benzomorphans; Cyclazocine; Dimethylphenylpiperazinium Iodide; Dogs; Ethylketocyclazocine; Gastrointestinal Motility; In Vitro Techniques; Intestine, Small; Morphine; Nalorphine; Phenazocine; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1985 |
Profile of activity of kappa receptor agonists in the rabbit vas deferens.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Benzodiazepines; Benzomorphans; Butorphanol; Cyclazocine; Ethylketocyclazocine; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Nalorphine; Naloxone; Pyrrolidines; Rabbits; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Vas Deferens | 1985 |
Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzomorphans; Butorphanol; Cyclazocine; Diuresis; Drinking; Ethylketocyclazocine; Female; Male; Nalorphine; Pyrrolidines; Rats; Rats, Inbred Strains; Rats, Zucker; Receptors, Opioid; Receptors, Opioid, kappa; Stereoisomerism; Vasopressins; Water Deprivation | 1987 |
Discriminative stimulus properties of nalorphine in the rhesus monkeys.
Topics: Animals; Benzodiazepines; Benzomorphans; Conditioning, Operant; Cyclazocine; Discrimination Learning; Dose-Response Relationship, Drug; Ethylketocyclazocine; Macaca mulatta; Male; Nalorphine; Naloxone; Phenazocine; Receptors, Opioid; Receptors, Opioid, kappa | 1983 |
Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Behavior, Animal; Benzeneacetamides; Benzofurans; Benzomorphans; Conditioning, Operant; Dose-Response Relationship, Drug; Ethylketocyclazocine; Nalorphine; Naltrexone; Narcotic Antagonists; Pyrroles; Pyrrolidines; Receptors, Opioid, kappa; Reinforcement Schedule; Saimiri; Thiophenes | 1999 |
Sex and rat strain determine sensitivity to kappa opioid-induced antinociception.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Benzofurans; Benzomorphans; Female; Male; Nalorphine; Narcotics; Pyrrolidines; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Sex Characteristics | 2002 |
Predicted structures for kappa opioid G-protein coupled receptor bound to selective agonists.
Topics: Benzomorphans; Binding Sites; Drug Design; Ethylketocyclazocine; Humans; Ligands; Models, Molecular; Molecular Docking Simulation; Morphine; Nalorphine; Pentazocine; Protein Conformation; Receptors, G-Protein-Coupled; Receptors, Opioid, kappa; Structure-Activity Relationship | 2015 |